Diagnostics
Real-world study shows that SelectMDx helps urologists more confidently determine the need for an initial prostate biopsy
Oxford Immunotec Global PLC today announced that it plans to release third quarter 2018 financial results prior to market open on Friday, November 9, 2018.
Company to Participate in USA Corporate Executive Office Program
Company to Participate in USA Corporate Executive Office Program
Epigenomics AG today announced the Veterans Administration - New York Harbor Healthcare System (VA-Manhattan) is commencing a study to assess the adherence impact of offering a blood-based colorectal cancer screening test and colonoscopy completion in patients who have refused colonoscopy and fecal immunochemical test (FIT).
Lucence Diagnostics today announced the launch of the world’s first molecular test to distinguish breast fibroadenoma, the commonest benign breast tumor, from phyllodes tumor, a less common tumor that may be malignant.
Molecular diagnostic programme for better cancer treatment kicks off
Hundreds of millions of dollars have been pledged by billionaires to advance scientific research.
The quantitative next-generation sequencing blood test for infectious diseases makes an international impact
The Baltimore Longitudinal Study of Aging was launched in 1958 by the National Institutes of Health. The idea was to follow and study the lives of healthy, active people over their lifetimes, rather than after they were dead.
PRESS RELEASES